Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 16/20 | 0.53 |
| ▸ | KDR | P35968 | 3/20 | 0.52 |
| ▸ | CDK1 | P06493 | 1/20 | 0.49 |
| ▸ | CDK2 | P24941 | 1/20 | 0.49 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7701963 | 0.86 | CHEK1 (0.57) | CHEK1KDRCDK1CDK2KCNH2 | |
| SCHEMBL7705633 | 0.85 | CHEK1 (0.56) | CHEK1KDRCDK1CDK2 | |
| SCHEMBL7698769 | 0.83 | KDR (0.58) | CHEK1KDRCDK1CDK2KCNH2 | |
| SCHEMBL7094008 | 0.82 | CHEK1 (0.50) | CHEK1KDRCDK1CDK2 | |
| SCHEMBL7702139 | 0.81 | CHEK1 (0.51) | CHEK1KDRCDK1CDK2KCNH2 | |
| SCHEMBL7701855 | 0.81 | NAMPT (0.64) | CHEK1KDRCDK1CDK2 | |
| SCHEMBL7705309 | 0.80 | KDR (0.69) | CHEK1KDRCDK1CDK2 | |
| SCHEMBL7705692 | 0.80 | CHEK1 (0.62) | CHEK1KDRCDK1CDK2 | |
| SCHEMBL7696882 | 0.79 | CHEK1 (0.51) | CHEK1KDRCDK1CDK2KCNH2 | |
| SCHEMBL7702362 | 0.79 | KDR (0.52) | CHEK1KDRCDK1CDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6462036-B1 | INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-08 | — | — | US | disclosed |